Vanguard amends 13G/A after Jan 12, 2026 realignment — ALKT
Rhea-AI Filing Summary
Alkami Technology Inc ownership update: The Vanguard Group filed Amendment No. 3 to its Schedule 13G/A reporting that it beneficially owns 0% of Alkami common stock, representing 0 shares as reported. The filing notes an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries to report ownership separately.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial position after internal disaggregation.
The filing shows 0 shares and 0% beneficial ownership; this is a clear statement of non‑ownership rather than a trading action. The January 12, 2026 realignment is cited as the reason subsidiaries now report separately.
Cash‑flow treatment and any related holdings by separate Vanguard entities are not detailed in the excerpt; subsequent filings by those entities may list holdings if applicable.
Amendment documents compliance with SEC release on disaggregated reporting.
The text references SEC Release No. 34-39538 and states that Vanguard subsidiaries will report beneficial ownership separately, and that Vanguard 'no longer has, or is deemed to have, beneficial ownership' over those subsidiary-held securities.
Filing signature is by the Head of Global Fund Administration on 03/26/2026, confirming the amendment execution.
FAQ
What stake does The Vanguard Group report in ALKT?
Why did Vanguard amend its Schedule 13G/A for ALKT?
Does this filing show any purchases or sales of ALKT by Vanguard?
Which Vanguard office signed the amendment for ALKT?
Does the filing identify holdings of Vanguard subsidiaries after realignment?